Morgan Stanley’s Surrozen SRZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$186K Sell
7,151
-15,295
-68% -$420K ﹤0.01% 5984
2026
Q1
$654K Sell
22,446
-14,515
-39% -$348K ﹤0.01% 5343
2025
Q4
$835K Buy
36,961
+2,197
+6% +$35.5K ﹤0.01% 5277
2025
Q3
$448K Hold
34,764
﹤0.01% 5545
2025
Q2
$311K Hold
34,764
﹤0.01% 5672
2025
Q1
$405K Hold
34,764
﹤0.01% 5426
2024
Q4
$499K Sell
34,764
-447
-1% -$4.74K ﹤0.01% 5419
2024
Q3
$422K Hold
35,211
﹤0.01% 5479
2024
Q2
$386K Hold
35,211
﹤0.01% 5407
2024
Q1
$553K Hold
35,211
﹤0.01% 5271
2023
Q4
$331K Sell
35,211
-1
-0% -$7 ﹤0.01% 5501
2023
Q3
$259K Hold
35,212
﹤0.01% 5465
2023
Q2
$290K Sell
35,212
-17,446
-33% -$164K ﹤0.01% 5473
2023
Q1
$476K Buy
52,658
+17,446
+50% +$213K ﹤0.01% 5284
2022
Q4
$307K Buy
35,212
+34,878
+10,443% +$737K ﹤0.01% 5480
2022
Q3
$10K Buy
+334
New +$14.1K ﹤0.01% 7071
2022
Q2
Sell
-2
Closed 7960
2022
Q1
$0 Sell
2
-3
-60% -$148 ﹤0.01% 8108
2021
Q4
$1K Buy
+5
New +$567 ﹤0.01% 7886

Other funds holding SRZN

Morgan Stanley's SRZN Position: Q2 2026 in Review

Morgan Stanley reduced its Surrozen (SRZN) stake by 68% in Q2 2026, selling an estimated $420K and leaving 7,151 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #5984.

Morgan Stanley first reported a position in SRZN in Q4 2021 and has held it in 18 quarters since. The position peaked at $835K in Q4 2025. 70 funds tracked by Wall St. Rank hold SRZN as of Q2 2026.

  • Morgan Stanley held 7,151 shares of Surrozen worth $186K as of Q2 2026.
  • Morgan Stanley sold 15,295 Surrozen shares in Q2 2026, an estimated $420K.
  • Surrozen made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5984 holding.
  • Morgan Stanley first reported a position in Surrozen in Q4 2021 and has held it in 18 quarters since.
  • Morgan Stanley's Surrozen position peaked at $835K in Q4 2025.
  • 70 funds tracked by Wall St. Rank held Surrozen as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.